Insider Selling: Intuitive Surgical (NASDAQ:ISRG) SVP Sells 645 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 645 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Thursday, March 5th, Mark Brosius sold 648 shares of Intuitive Surgical stock. The shares were sold at an average price of $495.20, for a total value of $320,889.60.
• On Wednesday, March 4th, Mark Brosius sold 2,362 shares of Intuitive Surgical stock. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16.
• On Tuesday, March 3rd, Mark Brosius sold 648 shares of Intuitive Surgical stock. The stock was sold at an average price of $488.10, for a total value of $316,288.80.
• On Monday, December 15th, Mark Brosius sold 464 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.49, for a total value of $254,499.36.
• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The stock was sold at an average price of $547.36, for a total transaction of $2,463,120.00.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $7.71 during midday trading on Tuesday, reaching $485.85. The stock had a trading volume of 1,545,337 shares, compared to its average volume of 2,028,645. The stock has a market capitalization of $172.54 billion, a P/E ratio of 61.58, a PEG ratio of 3.78 and a beta of 1.66. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88. The firm’s fifty day simple moving average is $520.00 and its 200-day simple moving average is $512.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.21 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently bought and sold shares of the business. PeakShares LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth about $1,040,000. Corient Private Wealth LLC lifted its stake in Intuitive Surgical by 17.7% during the fourth quarter. Corient Private Wealth LLC now owns 378,838 shares of the medical equipment provider’s stock worth $214,891,000 after purchasing an additional 57,055 shares during the period. Union Savings Bank acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $67,000. Storen Legacy Partners LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $217,000. Finally, Worthington Financial Partners LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at $366,000. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several recent analyst reports. UBS Group set a $570.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Tuesday, February 24th. Sanford C. Bernstein boosted their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Piper Sandler reiterated an “overweight” rating and set a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Finally, Truist Financial boosted their price objective on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.